Literature DB >> 17978881

Decompressive craniectomy for massive cerebral infarction with enlarged cruciate duraplasty.

Y Yao1, Y Mao, L Zhou.   

Abstract

The use of decompressive craniectomy for massive cerebral infarction is attracting renewed interest because conventional medical treatment is associated with high mortality. The technique of duraplasty may be important. We have developed a 4 step volume-enlarged cruciate duraplasty and report its use in 12 patients with massive cerebral infarction. None of the patients needed an additional anterior temporal lobectomy to reduce intraoperative intracranial pressure and none suffered epilepsy after the operation. This initial experience suggests that the use of a stepwise cruciate duraplasty during a decompression may promote clinical outcomes and further evaluation is merited.

Entities:  

Mesh:

Year:  2007        PMID: 17978881     DOI: 10.1007/s00701-007-1415-7

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  Managing malignant cerebral infarction.

Authors:  J Marc Simard; Juan Sahuquillo; Kevin N Sheth; Kristopher T Kahle; Brian P Walcott
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

Review 2.  Does size matter? Decompressive surgery under review.

Authors:  Arthur R Kurzbuch
Journal:  Neurosurg Rev       Date:  2015-04-12       Impact factor: 3.042

Review 3.  Life-saving decompressive craniectomy for diffuse cerebral edema during an episode of new-onset diabetic ketoacidosis: case report and review of the literature.

Authors:  Ha Son Nguyen; James D Callahan; Aaron A Cohen-Gadol
Journal:  Childs Nerv Syst       Date:  2010-09-21       Impact factor: 1.475

4.  Effects of unilateral decompressive craniectomy on patients with unilateral acute post-traumatic brain swelling after severe traumatic brain injury.

Authors:  Wusi Qiu; Chenchen Guo; Hong Shen; Keyong Chen; Liang Wen; Hongjie Huang; Min Ding; Li Sun; Qizhou Jiang; Weiming Wang
Journal:  Crit Care       Date:  2009-11-23       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.